In this context, it has been demonstrated that the down-regulation of PKCδ with prolonged phorbol-ester treatment of Src-overexpressing fibroblasts confers a malignant phenotype [71], suggesting a tumor-suppressor role for this isoform. This evidence concerns the gene PRKCD and neoplasm.